Medtech industry trends in 2024 and beyond
The medtech industry posted an uneven year in 2023. Among the reasons for celebration were expectation-beating revenue growth, a record number of novel-product approvals, and a spate of divestitures that helped companies refocus on their core capabilities. On the flip side, the growing popularity of glucagon-like peptide-1 (GLP-1) drugs for weight loss led investors to…
